There’s nary beauteous mode of putting it: Beyond Meat Inc.’s quarterly results could beryllium described arsenic dormant meat.
The company’s banal BYND, -3.58% was initially pummeled much than 17% successful extended trading Wednesday aft it reported a fiscal third-quarter nett nonaccomplishment of $54.8 million, oregon 87 cents a share, compared with a nett nonaccomplishment of $19.3 million, oregon 31 cents a share, successful the year-ago quarter. Adjusting for one-time losses, Beyond reported a nett nonaccomplishment of $36.8 million.
Revenue modestly improved 13% to $106.4 cardinal from $94.4 cardinal a twelvemonth ago.
Analysts polled by FactSet had forecast a nonaccomplishment of 37 cents a stock connected gross of $109.2 million.
“Our third-quarter results bespeak variability arsenic we saw a diminution from grounds nett revenues conscionable a 4th ago,” Beyond Meat Chief Executive Ethan Brown said successful a connection announcing the results. “Near-term marketplace and operating conditions notwithstanding, we stay committed to our semipermanent strategy.”
The gross forecast for the 4th fourth isn’t precisely sizzling, either. Beyond Meat projects betwixt $85 cardinal and $110 million. Analysts polled by FactSet person projected $130.5 million.
Investors had been bracing for the results. Company shares precocious dipped beneath $100 and skidded to a 52-week debased successful trading Oct. 22 aft Beyond warned of little third-quarter gross than antecedently forecast.
Beyond said it expected income of $106 million, beneath its anterior outlook of $120 cardinal to $140 million. Wall Street analysts surveyed by FactSet were anticipating gross of $109.2 cardinal for the quarter. The institution did not merchandise an outlook for its quarterly earnings, but analysts are expecting a nonaccomplishment of 37 cents a share.
Beyond executives past blamed the gross informing connected COVID-19, labour shortages, and operational challenges.
Shares of Beyond Meat shares are down 25% this year, portion the broader S&P 500 scale SPX, -0.82% has gained 23.7%.
/etf_analysis_proshares_ultrapro_nasdaq_biotech__ss-5bfc3af846e0fb0051c1e7d5.jpg)
English (US) ·